Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model

Journal of Vascular Surgery

Volumn 34, Issue 4, 2001, Pages 724-729

  Cruz, Carlos P ^a,b   Eidt, John ^a,b   Drouilhet, John ^a,b   Brown, Aliza T ^a,b   Wang, YunFang ^b   Barnes, Christopher S ^c   Moursi, Mohammed M ^a,b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; COLLAGEN; SALIVA PROTEIN; SARATIN; VON WILLEBRAND FACTOR;

ANIMAL; ARTICLE; BLEEDING TIME; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HYPERPLASIA; INJURY; INTIMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; RECURRENT DISEASE; SPRAGUE DAWLEY RAT; THROMBOCYTE ADHESIVENESS; THROMBOCYTE COUNT; THROMBOSIS; TIME; TOPICAL DRUG ADMINISTRATION; ULTRASTRUCTURE;

ADMINISTRATION, TOPICAL; ANIMALS; BLEEDING TIME; CAROTID ARTERIES; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDARTERECTOMY, CAROTID; HYPERPLASIA; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; SALIVARY PROTEINS; THROMBOSIS; TIME FACTORS; TUNICA INTIMA; VON WILLEBRAND FACTOR;

EID: 0035491108     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.116801     Document Type: Article

References (21)

1. Brott T, Thalinger K. The practice of carotid endarterectomy in a large metropolitan area. Stroke 1984;15:950-5.
2. Clagett GP, Robinowitz M, Youkey JR, Fisher DF Jr, Fry RE, Myers SI, et al. Morphogenesis and clinicopathologic characteristics of recurrent carotid disease. J Vasc Surg 1986;3:10-23.
3. Southern F, Cruz N, Fink L, Barone G, Eidt JF, Moursi MM, et al. Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 1998;28:909-18.
4. Law MM, Gelabert HA, Moore WS, Hajjar GE, Colburn MD, Petrik PV, et al. Cigarette smoking increases the development of intimal hyperplasia after vascular injury. J Vasc Surg 1996;23:401-9.
5. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (ACAS). Endarte recto my for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
6. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grate carotid stenosis. N Engl J Med 1991;325:445-53.
7. Hoch JR, Turnipseed WD, Acher CW. Evaluation of common femoral endarterectomy for the management of focal atherosclerotic disease. Vasc Surg 1999;33:461-70.
8. Kraiss LW, Clowes AW. Response of the arterial wall to injury and intimal hyperplasia. In: Sidawy AN, Sumpio BE, DePalma RG, editors. The basic science of vascular disease. 1st ed. Armonk(NY): Futura; 1997. p. 289-317.
9. Spallone A, Sasaki T, Kassell NF. Time course of thrombotic changes after microsurgical carotid endarterectomy in the rat. Neurosurgery 1985;16:773-9.
10. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-33.
11. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular surgery in rat carotid artery. Proc Natl Acad Sci USA 1989;86:8412-16.
12. Bowen-Pope DF, Ross R, Seifert RA. Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. Circulation 1985;72:735-40.
13. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia - a review. J Vasc Surg 1991;13:885-91.
14. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
15. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993;91:94-8.
16. Graham DJ, Alexander JJ. The effects of thrombin on bovine aortic endothelial and smooth muscle cells. J Vasc Surg 1990;11:307-13.
17. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neil J, Kramer J, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988;77:1238-44.
18. Connolly, TM, Jacobs, JW, Condra, C. An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis Leech. J Biol Chem 1992;267:6893-8.
19. Munro R, Jones CP, Sawyer RT. Calin - a platelet adhesion inhibitor from the saliva of the medicinal leech. Blood Coag Fibrinol 1991;2:179-84.
20. Harsfalvi J, Stassen JM, Hoylaerts MF, Van Houtte E, Sawyer RT, Vermylen J, et al. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 1995;85:705-11.
21. van Zanten GH, Connolly TM, Schiphorst ME, de Graaf S, Slootweg PJ, Sixma JJ. Recombinant leech antiplatelet protein specifically blocks platelet deposition on collagen surfaces under flow conditions. Arterioscler Thromb Vasc Biol 1995;15:1424-31.